IndraLab

Statements


AristA inhibits KCNK18. 2 / 2
| 2

reach
"AristA inhibits TRESK channel currents."

reach
"Enhancement of TREK-1 and TREK-2 and inhibition of TRESK by AristA may contribute to therapeutically useful effects of this compound in pain."